Ameriprise’s Wave Life Sciences WVE Stock Holding History

Ameriprise’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$293K	Sell	40,374 -358,042	-90%	-$4.66M	﹤0.01%	3767
2025 Q4	$6.77M	Buy	398,416 +290,551	+269%	+$2.95M	﹤0.01%	2211
2025 Q3	$790K	Buy	+107,865	New	+$873K	﹤0.01%	3467
2025 Q2	–	Sell	-10,830	Closed	-$87.5K	–	4145
2025 Q1	$87.5K	Buy	10,830 +416	+4%	+$4.55K	﹤0.01%	3897
2024 Q4	$129K	Buy	+10,414	New	+$139K	﹤0.01%	3924
2024 Q3	–	Sell	-25,994	Closed	-$130K	–	4024
2024 Q2	$130K	Sell	25,994 -350	-1%	-$2K	﹤0.01%	3747
2024 Q1	$163K	Buy	26,344 +345	+1%	+$1.73K	﹤0.01%	3716
2023 Q4	$131K	Buy	+25,999	New	+$139K	﹤0.01%	3785
2018 Q2	–	Sell	-23,516	Closed	-$943K	–	3708
2018 Q1	$943K	Buy	+23,516	New	+$989K	﹤0.01%	2992

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

GSK plc London $599M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Ameriprise's WVE Position: Q1 2026 in Review

Ameriprise reduced its Wave Life Sciences (WVE) stake by 90% in Q1 2026, selling an estimated $4.66M and leaving 40,374 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #3767.

Ameriprise first reported a position in WVE in Q1 2018 and has held it in 9 quarters since. The position peaked at $6.77M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

Ameriprise held 40,374 shares of Wave Life Sciences worth $293K as of Q1 2026.
Ameriprise sold 358,042 Wave Life Sciences shares in Q1 2026, an estimated $4.66M.
Wave Life Sciences made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3767 holding.
Ameriprise first reported a position in Wave Life Sciences in Q1 2018 and has held it in 9 quarters since.
Ameriprise's Wave Life Sciences position peaked at $6.77M in Q4 2025.
230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.